Posted by Michael Wonder on 16 Feb 2022
The new lightning rod in the fight over high drug prices
16 February 2022 - With the BBB Act on the ropes, some drug pricing advocacy organisations are turning their attention to a far more wonky topic.
A petition calling on the NIH to use so-called march in rights to lower the price of the prostate cancer drug Xtandi.
